[Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
He X, Ying Luan
Abstract
He X, Ying Luan
Abstract
The plasma gamma-aminobutyric acid (GABA) concentration was measured by a radio-receptor assay in rat model of hepatic encephalopathy due to fulminant hepatic failure (FHF) induced by intraperitoneal injection of D-galactosamine (GalN). The results showed that, in FHF group, the plasma GABA increased parallelly with the degree of hepatic encephalopathy after GalN i.p. (r = 0.944, P less than 0.05). In about 48 h, mean plasma GABA concentration was elevated nearly 8-fold. These findings suggest that, in liver failure, elevated plasma GABA concentration may play a role in the pathogenesis of hepatic encephalopathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The plasma gamma-aminobutyric acid (GABA) concentration was measured by a radio-receptor assay in rat model of hepatic encephalopathy due to fulminant hepatic failure (FHF) induced by intraperitoneal injection of D-galactosamine (GalN). The results showed that, in FHF group, the plasma GABA increased parallelly with the degree of hepatic encephalopathy after GalN i.p. (r = 0.944, P less than 0.05). In about 48 h, mean plasma GABA concentration was elevated nearly 8-fold. These findings suggest that, in liver failure, elevated plasma GABA concentration may play a role in the pathogenesis of hepatic encephalopathy.
Key concepts: Fulminant hepatic failure, Hepatic encephalopathy, Internal medicine, Galactosamine, Endocrinology, Pathogenesis, Encephalopathy, Intraperitoneal injection